RecruitingNot ApplicableNCT06701084

Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis

Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis: Gene-Shortening Time of Evaluation in Pediatric Epilepsy Services (Gene-STEPS)


Sponsor

Boston Children's Hospital

Enrollment

600 participants

Start Date

Sep 2, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to discover new genetic causes of infantile epilepsies and evaluate the impact of these discoveries on infants with epilepsy and their families.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Genomic Sequencing for people with infantile epilepsy and neonatal epilepsy. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICGenomic Sequencing

Genomic sequencing data will be comprehensively analyzed for pathogenic variants that explain the participants epilepsy.


Locations(1)

Boston Children's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06701084